Objectif Evaluer chez des hommes âgés la rentabilité de la densitométrie osseuse suivie par
un traitement de 5 ans avec des biphosphonates par voie orale en vue de prévenir les …

ContextOsteoporotic fractures are common among elderly men. ObjectiveTo evaluate
among older men the cost-effectiveness of bone densitometry followed by 5 years of oral …

Fracture risk in women who dis-continue therapy with bisphosphonates can be assessed by
measuring bone mineral density at the time of discontinuation, but subsequent frequent …

IN THE 10 YEARS SINCE THE FIRST RESULTS FROM THE FRAC-ture Intervention Trial
(FIT) were published, 1, 2 it has been relatively straightforward to know when to start …

Bisphosphonates (BPs) are the most commonly used medications for osteoporosis. This
ASBMR report provides guidance on BP therapy duration with a risk‐benefit perspective …

Osteoporosis results in approximately one-half of older white women and one-third of men
sustaining fractures, which cause significant disability and increased mortality. Interventions …

Oral bisphosphonates significantly reduce clinical fracture risk at four years in women with
postmenopausal osteoporosis (T-score less than-2.5). Treatment beyond five years is …

The focus of this chapter is on the pharmacologic agents with the best clinical trial evidence
for the treatment of postmenopausal women with osteoporosis, the bisphosphonates. The …

Bon, mauvais ou ni l'un ni l'autre? Les bisphosphonates s' utilisent dans le monde entier
pour prévenir les fractures ostéoporotiques. Ils diminuent la résorption osseuse et …

Continuing Bisphosphonate Treatment for Osteoporosis — For Whom and for How Long? |
NEJM Skip to main content NEJM Group Follow Us Facebook Twitter Instagram YouTube …